Vascular Biogenics Ltd. logo
Vascular Biogenics Ltd. VBLT
$ 0.16 -8.77%

Quarterly report 2024-Q2
added 08-14-2024

report update icon

Vascular Biogenics Ltd. Financial Statements 2011-2024 | VBLT

Annual Financial Statements Vascular Biogenics Ltd.

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

528 K 98.3 K 131 M 109 M 54.9 M 42.5 M 197 M 127 M 61.3 M 19.4 T - - -

Shares

3.3 M 656 K 66.3 M 43.7 M 35.9 M 33 M 27.4 M 25 M 19.9 M 1.23 T - - -

Historical Prices

0.16 0.15 1.97 1.89 1.2 0.97 7.1 4.85 5.26 5.91 - - -

Net Income

-11.3 M -14.4 M -29.9 M -24.2 M -19.5 M -20.5 M -10.1 M - - - -16 M -12.2 M -

Revenue

310 K 8 K 768 K 922 K 562 K 585 K 13.9 M - - - - - -

Cost of Revenue

197 K 104 K 365 K 394 K 222 K 255 K - - - - - - -

Gross Profit

113 K 8 K 403 K 528 K 399 K 350 K 13.5 M - - - - - -

Operating Income

-14.7 M -12.9 M -30 M -24.5 M -20.1 M 21.2 M - - - - - - -

Interest Expense

179 K 1.03 M 44 K 105 K 184 K 159 K - - - - - - -

EBITDA

-14.4 M -12.6 M -28.7 M -23.3 M -18.3 M -20.1 M -10.5 M 130 K 122 K 135 K -16.1 M -12.3 M -

Operating Expenses

14.8 M 12.9 M - 25 M 20.4 M 21.6 M 24.2 M 16.3 M 14.9 M 14.8 M 16 M - -

General and Administrative Expenses

10.1 M 5.16 M 7.7 M 5.36 M 5.22 M 5.71 M 5.8 M 3.83 M -131 K 1.35 M 3.79 M 1.88 M -

All numbers in USD currency

Quarterly Income Statement Vascular Biogenics Ltd.

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

9.46 M 9.02 M 9.02 M 2.24 M 970 K 970 K 1.99 M 2.22 M 77.4 M 77.4 M 68.7 M 70.3 M 68.1 M 52.1 M 48.2 M 47.9 M 42.7 M 36.1 M 35.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-5.22 M -3.77 M - -1.07 M -3.44 M -6.27 M - -9.17 M -9.43 M -10.4 M - -6.5 M -8.03 M -6.28 M - -5.78 M -5.83 M 5.35 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

2 K 1 K - - - - - 481 K 64 K 113 K - 199 K 188 K 185 K - 193 K 158 K 366 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - 2 K - 63 K 34 K 55 K - 91 K 89 K 90 K - 132 K 21 K 145 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

2 K 1 K - - - -2 K - 418 K 30 K 58 K - 108 K 99 K 95 K - 61 K 137 K 221 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-5.38 M -3.84 M - -1 M -2.99 M -5.52 M - -9.28 M -9.61 M -10.6 M - -6.51 M -8.02 M -6.35 M - -5.82 M -5.86 M 5.63 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

61 K 61 K - 63 K 1 K 16 K - 35 K 25 K 10 K - 8 K 7 K 20 K - 13 K 11 K 15 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- -3.78 M - - - -5.45 M - -9.28 M -9.61 M -10.2 M - -6.51 M -8.02 M -6.05 M - -5.82 M -5.86 M 5.93 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

5.38 M 3.84 M - - 2.99 M 5.52 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

3.03 M 2.29 M - 1.85 M 1.93 M 3.92 M - 3.75 M 2.92 M 3.16 M - 1.62 M 1.48 M 1.67 M - 1.28 M 1.34 M 1.34 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency